Your session is about to expire
← Back to Search
Behavioural Intervention
Optimizing Soft Speech Recognition in Children With Hearing Loss (SoftSpeech Trial)
N/A
Waitlist Available
Research Sponsored by Sonova AG
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 of 1 day study
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a new hearing aid feature called Soft Speech Enhancer to help children with moderate to severe hearing loss hear quiet speech better. The feature amplifies soft sounds, making it easier for these children to understand words and improve their language skills.
Eligible Conditions
- Sensorineural Hearing Loss
- Bilateral Hearing Loss
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1 of 1 day study
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 of 1 day study
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Speech Recognition in Quiet Using CNC (Consonant-Nucleus-Consonant) Word Lists
Secondary study objectives
Subjective Ratings of Speech Enhancer
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Children with Hearing LossExperimental Treatment1 Intervention
Participants age 5-12 with hearing loss who will be fit with study hearing aids and tested on speech perception in unaided and aided condition.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Phonak Audeo P or Naida P hearing aid
2022
N/A
~40
Find a Location
Who is running the clinical trial?
Hearts for HearingUNKNOWN
5 Previous Clinical Trials
160 Total Patients Enrolled
Sonova AGLead Sponsor
82 Previous Clinical Trials
1,931 Total Patients Enrolled